Stephan Wnendt
20Patents
7h-index
36Co-inventors
69Inventor score
Filing activity: Jul 20, 1993 → Jun 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7037269B2 | Ultrasonic imagining catheters | Emerging Cross-Sectional Technologies | 84 | Expired |
| US7762954B2 | Ultrasonic imaging catheters | Emerging Cross-Sectional Technologies | 84 | Active |
| US8819928B2 | Ultrasonic imaging catheters | Emerging Cross-Sectional Technologies | 19 | Active |
| US6500845B1 | Lactam derivatives as immunomodulating agents | Chemistry; Metallurgy | 13 | Expired |
| US6417197B1 | Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5681721A | Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect | Human Necessities | 9 | Expired |
| US6110941A | Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones | Human Necessities | 9 | Expired |
| US6004963A | Substituted 2, 4-imidazolidinedione compounds as pharmaceutical active ingredients | Chemistry; Metallurgy | 6 | Expired |
| US7183436B2 | Substituted 4-aminocyclohexanols | Chemistry; Metallurgy | 5 | Expired |
| US5976841A | Proteins having fibrinolytic and coagulation--inhibiting properties | Chemistry; Metallurgy | 4 | Expired |
| US7678834B2 | Substituted 4-aminocyclohexanol compounds | Chemistry; Metallurgy | 4 | Active |
| US5747291A | Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect | Human Necessities | 3 | Expired |
| US6476044B1 | Use of morphine derivatives as medicaments for the treatment of neuropathic problems | Human Necessities | 2 | Expired |
| US6133011A | Chimeric proteins having fibrinolytic and thrombin-inhibiting properties | Chemistry; Metallurgy | 2 | Expired |
| US10687527B2 | Container system for transport of biological material, uses thereof and methods of packaging | Performing Operations; Transporting | 1 | Active |
| US6509368B1 | Use of catechol derivatives as proteinase inhibitors | Human Necessities | 0 | Expired |
| US11723358B2 | Container system for transport of biological material, uses thereof and methods of packaging | Performing Operations; Transporting | 0 | Active |
| US8613906B2 | Treatment of ischemia using stem cells | Human Necessities | 0 | Active |
| US7012099B2 | Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments | Human Necessities | 0 | Expired |
| US8187320B2 | Medical implants containing FK506 (tacrolimus) | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.